Genus plc (GNSL.XC)
Cboe UK · GBp · Healthcare · Biotechnology
£2,335.00 (+0.65%) as of
Key statistics
- Market cap
- 1.55B
- P/E (TTM)
- 5.49
- EPS (TTM)
- 4.25
- Dividend yield
- 1.42%
- 52-week range
- 1,970.00 – 3,220.00
- Beta
- 0.90
- Revenue (TTM)
- 658.1M
- Profit margin
- 43.35%
- Volume
- 7.86k
About Genus plc
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Basingstoke, United Kingdom
- Employees
- 2,921
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- SCHINDLER HOLDING AG SCHINDLER (0QO1.IL)
- ALCON AG ALCON ORD SHS (0A0D.IL)
- International Public Partnershi (INPPL.XC)
- GCP ASSET BACKED INCOME FUND LI (GABI.L)
- Gamma Communications PLC (GAMAL.XC)
- UBS GROUP AG UBS GROUP REGISTER (0R3T.IL)
- FDM GROUP (HOLDINGS) PLC ORD 1P (FDM.L)
- MERCEDES-BENZ GROUP AG MERCEDES (0NXX.IL)